• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环鸟苷酸升高剂在肺动脉高压治疗中的分子机制。

A molecular mechanism for therapeutic effects of cGMP-elevating agents in pulmonary arterial hypertension.

机构信息

Department of Medicine, University of California San Diego, La Jolla, California 92093.

Institute for Pharmacology and Toxicology, University of Bonn, 53113 Bonn, Germany.

出版信息

J Biol Chem. 2013 Jun 7;288(23):16557-16566. doi: 10.1074/jbc.M113.458729. Epub 2013 Apr 23.

DOI:10.1074/jbc.M113.458729
PMID:23612967
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3675591/
Abstract

Pulmonary arterial hypertension (PAH) is a progressive, usually fatal disease with abnormal vascular remodeling. Pulmonary artery smooth muscle cells (PASMCs) from PAH patients are hyperproliferative and apoptosis-resistant and demonstrate decreased signaling in response to bone morphogenetic proteins (BMPs). Cyclic GMP-elevating agents are beneficial in PAH, but their mechanism(s) of action are incompletely understood. Here we show that BMP signaling via Smad1/5/8 requires cGMP-dependent protein kinase isotype I (PKGI) to maintain PASMCs in a differentiated, low proliferative state. BMP cooperation with cGMP/PKGI was crucial for transcription of contractile genes and suppression of pro-proliferative and anti-apoptotic genes. Lungs from mice with low or absent PKGI (Prkg1(+/-) and Prkg1(-/-) mice) exhibited impaired BMP signaling, decreased contractile gene expression, and abnormal vascular remodeling. Conversely, cGMP stimulation of PKGI restored defective BMP signaling in rats with hypoxia-induced PAH, consistent with cGMP-elevating agents reversing vascular remodeling in this PAH model. Our results provide a mechanism for the therapeutic effects of cGMP-elevating agents in PAH and suggest that combining them with BMP mimetics may provide a novel, disease-modifying approach to PAH therapy.

摘要

肺动脉高压(PAH)是一种进行性的、通常致命的疾病,伴有异常的血管重塑。PAH 患者的肺动脉平滑肌细胞(PASMCs)过度增殖且凋亡抵抗,并表现出对骨形态发生蛋白(BMPs)的信号反应降低。环鸟苷酸(cGMP)升高剂对 PAH 有益,但它们的作用机制尚不完全清楚。在这里,我们表明 BMP 信号通过 Smad1/5/8 需要 cGMP 依赖性蛋白激酶同工型 I(PKGI)来维持 PASMCs 的分化和低增殖状态。BMP 与 cGMP/PKGI 的合作对于收缩基因的转录和抑制促增殖和抗凋亡基因至关重要。PKGI 低表达或缺失(Prkg1(+/-)和 Prkg1(-/-)小鼠)的小鼠肺部表现出 BMP 信号受损、收缩基因表达减少和血管重塑异常。相反,cGMP 刺激 PKGI 恢复了缺氧诱导的 PAH 大鼠中缺陷的 BMP 信号,这与 cGMP 升高剂在该 PAH 模型中逆转血管重塑的作用一致。我们的研究结果为 cGMP 升高剂在 PAH 中的治疗效果提供了一种机制,并表明将它们与 BMP 模拟物联合使用可能为 PAH 治疗提供一种新的、疾病修饰的方法。

相似文献

1
A molecular mechanism for therapeutic effects of cGMP-elevating agents in pulmonary arterial hypertension.环鸟苷酸升高剂在肺动脉高压治疗中的分子机制。
J Biol Chem. 2013 Jun 7;288(23):16557-16566. doi: 10.1074/jbc.M113.458729. Epub 2013 Apr 23.
2
Sildenafil potentiates bone morphogenetic protein signaling in pulmonary arterial smooth muscle cells and in experimental pulmonary hypertension.西地那非增强肺动脉平滑肌细胞和成骨蛋白信号转导,并在实验性肺动脉高压中。
Arterioscler Thromb Vasc Biol. 2013 Jan;33(1):34-42. doi: 10.1161/ATVBAHA.112.300121. Epub 2012 Nov 8.
3
Smad-dependent and smad-independent induction of id1 by prostacyclin analogues inhibits proliferation of pulmonary artery smooth muscle cells in vitro and in vivo.前列环素类似物通过 Smad 依赖和 Smad 非依赖途径诱导 id1 的表达,抑制肺动脉平滑肌细胞的体外和体内增殖。
Circ Res. 2010 Jul 23;107(2):252-62. doi: 10.1161/CIRCRESAHA.109.209940. Epub 2010 Jun 3.
4
BRCC3 Regulation of ALK2 in Vascular Smooth Muscle Cells: Implication in Pulmonary Hypertension.BRCC3 调控血管平滑肌细胞中的 ALK2:在肺动脉高压中的意义。
Circulation. 2024 Jul 9;150(2):132-150. doi: 10.1161/CIRCULATIONAHA.123.066430. Epub 2024 Apr 1.
5
Steroid-sensitive gene 1 is a novel cyclic GMP-dependent protein kinase I substrate in vascular smooth muscle cells.甾体敏感基因 1 是血管平滑肌细胞中环磷酸鸟苷依赖蛋白激酶 I 的一种新型底物。
J Biol Chem. 2013 Aug 23;288(34):24972-83. doi: 10.1074/jbc.M113.456244. Epub 2013 Jul 6.
6
Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension.功能失调的Smad信号传导导致家族性肺动脉高压中平滑肌细胞异常增殖。
Circ Res. 2005 May 27;96(10):1053-63. doi: 10.1161/01.RES.0000166926.54293.68. Epub 2005 Apr 21.
7
Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.骨形态发生蛋白系统在肺动脉高压患者肺动脉平滑肌细胞中内皮素和醛固酮诱导的细胞增殖中的作用。
Hypertens Res. 2010 May;33(5):435-45. doi: 10.1038/hr.2010.16. Epub 2010 Feb 26.
8
Sildenefil increases connexin 40 in smooth muscle cells through activation of BMP pathways in pulmonary arterial hypertension.西地那非通过激活肺动脉高压中骨形态发生蛋白(BMP)信号通路增加平滑肌细胞中连接蛋白40的表达。
Int J Clin Exp Pathol. 2014 Jul 15;7(8):4674-84. eCollection 2014.
9
Sildenafil inhibits hypoxia-induced transient receptor potential canonical protein expression in pulmonary arterial smooth muscle via cGMP-PKG-PPARγ axis.西地那非通过 cGMP-PKG-PPARγ 轴抑制低氧诱导的肺动脉平滑肌瞬时受体电位经典型蛋白表达。
Am J Respir Cell Mol Biol. 2013 Aug;49(2):231-40. doi: 10.1165/rcmb.2012-0185OC.
10
FGF12 (Fibroblast Growth Factor 12) Inhibits Vascular Smooth Muscle Cell Remodeling in Pulmonary Arterial Hypertension.成纤维细胞生长因子 12(Fibroblast Growth Factor 12)抑制肺动脉高压中的血管平滑肌细胞重构。
Hypertension. 2020 Dec;76(6):1778-1786. doi: 10.1161/HYPERTENSIONAHA.120.15068. Epub 2020 Oct 26.

引用本文的文献

1
Nitric oxide regulation of fetal and newborn lung development and function.一氧化氮对胎儿和新生儿肺发育和功能的调节。
Nitric Oxide. 2024 Jun 1;147:13-25. doi: 10.1016/j.niox.2024.04.005. Epub 2024 Apr 7.
2
Activating NO-sGC crosstalk in the mouse vascular niche promotes vascular integrity and mitigates acute lung injury.激活小鼠血管龛中的 NO-sGC 串扰可促进血管完整性并减轻急性肺损伤。
J Exp Med. 2023 Feb 6;220(2). doi: 10.1084/jem.20211422. Epub 2022 Nov 9.
3
Phosphoproteomic analysis of lung tissue from patients with pulmonary arterial hypertension.肺动脉高压患者肺组织的磷酸化蛋白质组学分析
Pulm Circ. 2021 Aug 19;11(3):20458940211031109. doi: 10.1177/20458940211031109. eCollection 2021 Jul-Sep.
4
Therapy for Pulmonary Arterial Hypertension: Glance on Nitric Oxide Pathway.肺动脉高压的治疗:一氧化氮途径概述
Front Pharmacol. 2021 Nov 12;12:767002. doi: 10.3389/fphar.2021.767002. eCollection 2021.
5
IRAG1 Deficient Mice Develop PKG1β Dependent Pulmonary Hypertension.IRAG1 缺陷小鼠发生依赖于 PKG1β 的肺动脉高压。
Cells. 2020 Oct 13;9(10):2280. doi: 10.3390/cells9102280.
6
Aortic pathology from protein kinase G activation is prevented by an antioxidant vitamin B analog.蛋白激酶 G 激活导致的主动脉病变可被抗氧化维生素 B 类似物预防。
Nat Commun. 2019 Aug 6;10(1):3533. doi: 10.1038/s41467-019-11389-1.
7
Treatment Selection in Pulmonary Arterial Hypertension: Phosphodiesterase Type 5 Inhibitors versus Soluble Guanylate Cyclase Stimulator.肺动脉高压的治疗选择:5型磷酸二酯酶抑制剂与可溶性鸟苷酸环化酶刺激剂
Eur Cardiol. 2018 Aug;13(1):35-37. doi: 10.15420/ecr.2017:22:2.
8
The Gyc76C Receptor Guanylyl Cyclase and the Foraging cGMP-Dependent Kinase Regulate Extracellular Matrix Organization and BMP Signaling in the Developing Wing of Drosophila melanogaster.Gyc76C受体鸟苷酸环化酶和觅食cGMP依赖性激酶调节黑腹果蝇发育翅膀中的细胞外基质组织和骨形态发生蛋白信号传导。
PLoS Genet. 2015 Oct 6;11(10):e1005576. doi: 10.1371/journal.pgen.1005576. eCollection 2015 Oct.
9
A novel crosstalk between Alk7 and cGMP signaling differentially regulates brown adipocyte function.Alk7与cGMP信号之间的一种新型串扰差异调节棕色脂肪细胞功能。
Mol Metab. 2015 Jun 14;4(8):576-83. doi: 10.1016/j.molmet.2015.06.003. eCollection 2015 Aug.
10
Pulmonary hypertension in obstructive sleep apnea: is it clinically significant? A critical analysis of the association and pathophysiology.阻塞性睡眠呼吸暂停中的肺动脉高压:具有临床意义吗?对其关联及病理生理学的批判性分析
Pulm Circ. 2015 Jun;5(2):220-7. doi: 10.1086/679995.

本文引用的文献

1
Cyclic guanosine monophosphate signalling pathway in pulmonary arterial hypertension.肺动脉高压中的环鸟苷酸单磷酸信号通路。
Vascul Pharmacol. 2013 Mar;58(3):211-8. doi: 10.1016/j.vph.2012.09.001. Epub 2012 Sep 12.
2
The soluble guanylate cyclase stimulator riociguat ameliorates pulmonary hypertension induced by hypoxia and SU5416 in rats.可溶性鸟苷酸环化酶刺激剂 riociguat 可改善缺氧和 SU5416 诱导的大鼠肺动脉高压。
PLoS One. 2012;7(8):e43433. doi: 10.1371/journal.pone.0043433. Epub 2012 Aug 17.
3
Protein kinase G-I deficiency induces pulmonary hypertension through Rho A/Rho kinase activation.蛋白激酶 G-I 缺乏通过 Rho A/Rho 激酶激活诱导肺动脉高压。
Am J Pathol. 2012 Jun;180(6):2268-75. doi: 10.1016/j.ajpath.2012.02.016.
4
Mechanisms of disease: pulmonary arterial hypertension.发病机制:肺动脉高压。
Nat Rev Cardiol. 2011 Jun 21;8(8):443-55. doi: 10.1038/nrcardio.2011.87.
5
Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease.可溶性鸟苷酸环化酶作为心肺疾病中一个新兴的治疗靶点。
Circulation. 2011 May 24;123(20):2263-73. doi: 10.1161/CIRCULATIONAHA.110.981738.
6
Structure, function and mechanism of the anaphase promoting complex (APC/C).有丝分裂后期促进复合物(APC/C)的结构、功能和机制。
Q Rev Biophys. 2011 May;44(2):153-90. doi: 10.1017/S0033583510000259. Epub 2010 Nov 22.
7
Reduced levels of two modifiers of epigenetic gene silencing, Dnmt3a and Trim28, cause increased phenotypic noise.两种表观遗传基因沉默修饰物 Dnmt3a 和 Trim28 的水平降低会导致表型噪声增加。
Genome Biol. 2010;11(11):R111. doi: 10.1186/gb-2010-11-11-r111. Epub 2010 Nov 19.
8
cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.环鸟苷酸依赖性蛋白激酶和环鸟苷酸磷酸二酯酶在一氧化氮和环鸟苷酸作用中的研究
Pharmacol Rev. 2010 Sep;62(3):525-63. doi: 10.1124/pr.110.002907.
9
Formation of plexiform lesions in experimental severe pulmonary arterial hypertension.实验性重度肺动脉高压中丛状病变的形成。
Circulation. 2010 Jun 29;121(25):2747-54. doi: 10.1161/CIRCULATIONAHA.109.927681. Epub 2010 Jun 14.
10
Smad-dependent and smad-independent induction of id1 by prostacyclin analogues inhibits proliferation of pulmonary artery smooth muscle cells in vitro and in vivo.前列环素类似物通过 Smad 依赖和 Smad 非依赖途径诱导 id1 的表达,抑制肺动脉平滑肌细胞的体外和体内增殖。
Circ Res. 2010 Jul 23;107(2):252-62. doi: 10.1161/CIRCRESAHA.109.209940. Epub 2010 Jun 3.